167 related articles for article (PubMed ID: 31549868)
21. Strategies for a comprehensive understanding of metabolism by aldehyde oxidase.
Hutzler JM; Obach RS; Dalvie D; Zientek MA
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):153-68. PubMed ID: 23231678
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of vertebrate aldehyde oxidase as a therapeutic treatment for cancer, obesity, aging and amyotrophic lateral sclerosis.
Qiao Y; Maiti K; Sultana Z; Fu L; Smith R
Eur J Med Chem; 2020 Feb; 187():111948. PubMed ID: 31877540
[TBL] [Abstract][Full Text] [Related]
23. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
Torres RA; Korzekwa KR; McMasters DR; Fandozzi CM; Jones JP
J Med Chem; 2007 Sep; 50(19):4642-7. PubMed ID: 17718551
[TBL] [Abstract][Full Text] [Related]
24. The first mammalian aldehyde oxidase crystal structure: insights into substrate specificity.
Coelho C; Mahro M; Trincão J; Carvalho AT; Ramos MJ; Terao M; Garattini E; Leimkühler S; Romão MJ
J Biol Chem; 2012 Nov; 287(48):40690-702. PubMed ID: 23019336
[TBL] [Abstract][Full Text] [Related]
25. Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model.
Zhao J; Cui R; Wang L; Chen Y; Fu Z; Ding X; Cui C; Yang T; Li X; Xu Y; Chen K; Luo X; Jiang H; Zheng M
J Med Chem; 2020 Jun; 63(12):6523-6537. PubMed ID: 32191458
[TBL] [Abstract][Full Text] [Related]
26. Increasing recognition of the importance of aldehyde oxidase in drug development and discovery.
Garattini E; Terao M
Drug Metab Rev; 2011 Aug; 43(3):374-86. PubMed ID: 21428696
[TBL] [Abstract][Full Text] [Related]
27. Drug-metabolizing ability of molybdenum hydroxylases.
Kitamura S; Sugihara K; Ohta S
Drug Metab Pharmacokinet; 2006 Apr; 21(2):83-98. PubMed ID: 16702728
[TBL] [Abstract][Full Text] [Related]
28. Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro-In Vivo Comparisons.
Wilkinson DJ; Southall RL; Li M; Wright LM; Corfield LJ; Heeley TA; Bratby B; Mannu R; Johnson SL; Shaw V; Friett HL; Blakeburn LA; Kendrick JS; Otteneder MB
AAPS J; 2017 Jul; 19(4):1163-1174. PubMed ID: 28474310
[TBL] [Abstract][Full Text] [Related]
29. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
30. Molecular Cloning and Characterization of Marmoset Aldehyde Oxidase.
Uehara S; Uno Y; Okamoto E; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 Aug; 45(8):883-886. PubMed ID: 28487309
[TBL] [Abstract][Full Text] [Related]
31. Medicinal chemistry approaches to avoid aldehyde oxidase metabolism.
Pryde DC; Tran TD; Jones P; Duckworth J; Howard M; Gardner I; Hyland R; Webster R; Wenham T; Bagal S; Omoto K; Schneider RP; Lin J
Bioorg Med Chem Lett; 2012 Apr; 22(8):2856-60. PubMed ID: 22429467
[TBL] [Abstract][Full Text] [Related]
32. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
Zientek MA; Youdim K
Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde oxidase importance in vivo in xenobiotic metabolism: imidacloprid nitroreduction in mice.
Swenson TL; Casida JE
Toxicol Sci; 2013 May; 133(1):22-8. PubMed ID: 23462233
[TBL] [Abstract][Full Text] [Related]
34. A rapid and sensitive fluorometric method for determination of aldehyde oxidase activity.
Apenova N; Peng H; Hecker M; Brinkmann M
Toxicol Appl Pharmacol; 2018 Feb; 341():30-37. PubMed ID: 29329804
[TBL] [Abstract][Full Text] [Related]
35. Non-cytochrome P450 enzyme aldehyde oxidase is involved in the oxidative metabolic pathway of diquat and its detoxification effect.
Mao Z; Yu Y; Ba G; Zhao H; Shi Q; Cao Y; Xie W; Zhang J; Sun H; Chen F
Pestic Biochem Physiol; 2024 Feb; 199():105805. PubMed ID: 38458670
[TBL] [Abstract][Full Text] [Related]
36. Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues.
Hammid A; Fallon JK; Vellonen KS; Lassila T; Reinisalo M; Urtti A; Gonzalez F; Tolonen A; Smith PC; Honkakoski P
Eur J Pharm Sci; 2023 Dec; 191():106603. PubMed ID: 37827455
[TBL] [Abstract][Full Text] [Related]
37. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
38. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
Kitamura S; Sugihara K
Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
[TBL] [Abstract][Full Text] [Related]
39. Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery.
Manevski N; King L; Pitt WR; Lecomte F; Toselli F
J Med Chem; 2019 Dec; 62(24):10955-10994. PubMed ID: 31385704
[TBL] [Abstract][Full Text] [Related]
40. Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase.
Jones JP; Korzekwa KR
Mol Pharm; 2013 Apr; 10(4):1262-8. PubMed ID: 23363487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
